Search results for : mos - Cancerrxgene - Genomics of Drug Sensitivity in Cancer

Name	Synonyms	Targets	Target Pathway	PubCHEM	Datatset	Sample size	Screening site
Bromosporine	ethyl N-[6-(3-methanesulfonamido-4-methylphenyl)-3-methyl-[1,2,4]triazolo[4,3-b]pyridazin-8-yl]carbamate	CECR2, BRD2, BRD4, BRD9	Chromatin other		GDSC2	716	SANGER

Name	Cell Model Passport Link	COSMIC ID	Tissue	Tissue sub-type
Ramos-2G6-4C10	SIDM01247	910401	UNCLASSIFIED	Blood
Ramos-2G6-4C10	SIDM01247	910401	UNCLASSIFIED	Blood

The Genomics of Drug Sensitivity in Cancer Project is a collaboration between the Cancer Genome Project at the Wellcome Sanger Institute (UK) and the Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center (USA). This work is funded by Wellcome.

Users have a non-exclusive, non-transferable right to use data files for internal proprietary research and educational purposes, including target, biomarker and drug discovery. Excluded from this licence are use of the data (in whole or any significant part) for resale either alone or in combination with additional data/product offerings, or for provision of commercial services.
Please note: The data files are experimental and academic in nature and are not licensed or certified by any regulatory body. Genome Research Limited provides access to data files on an “as is” basis and excludes all warranties of any kind (express or implied).

Genomics of Drug Sensitivity in Cancer

Search Results for: mos